Stewart McCallum
2017
In 2017, Stewart McCallum earned a total compensation of $1.2M as Chief Medical Officer at Recro Pharma, a 73% increase compared to previous year.
Compensation breakdown
| Bonus | $44,439 |
|---|---|
| Non-Equity Incentive Plan | $177,061 |
| Option Awards | $189,720 |
| Salary | $442,652 |
| Stock Awards | $285,870 |
| Other | $41,634 |
| Total | $1,181,376 |
McCallum received $442.7K in salary, accounting for 37% of the total pay in 2017.
McCallum also received $44.4K in bonus, $177.1K in non-equity incentive plan, $189.7K in option awards, $285.9K in stock awards and $41.6K in other compensation.
Rankings
In 2017, Stewart McCallum's compensation ranked 8,182nd out of 14,666 executives tracked by ExecPay. In other words, McCallum earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,182 out of 14,666 | 44th |
Division Manufacturing | 3,090 out of 5,768 | 46th |
Major group Chemicals And Allied Products | 1,018 out of 2,074 | 51st |
Industry group Drugs | 800 out of 1,730 | 54th |
Industry Pharmaceutical Preparations | 627 out of 1,329 | 53rd |
Source: SEC filing on March 23, 2018.
McCallum's colleagues
We found two more compensation records of executives who worked with Stewart McCallum at Recro Pharma in 2017.